Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RET |
Variant | G810R |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | RET G810R lies within the protein kinase domain of the Ret protein (UniProt.org). G810R is associated with RET inhibitor resistance in the context of RET fusions (PMID: 31988000, PMID: 33161056, PMID: 34373541), but has not been biochemically characterized and therefore, its effect on Ret protein function is unknown (PubMed, Jun 2024). |
Associated Drug Resistance | Y |
Category Variants Paths |
RET mutant RET G810R |
Transcript | NM_020975.6 |
gDNA | chr10:g.43119566G>C |
cDNA | c.2428G>C |
Protein | p.G810R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_020630 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_001406743.1 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_020975 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_020630.7 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_020975.5 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_020975.6 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_020630.5 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_001406744.1 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_001406759.1 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
NM_001406760.1 | chr10:g.43119566G>C | c.2428G>C | p.G810R | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RET G810R | Advanced Solid Tumor | predicted - sensitive | TPX-0046 | Preclinical - Cell culture | Actionable | In a preclinical study, TPX-0046 treatment led to inhibition of cell proliferation in a transformed cell line expressing RET G810R in culture (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 3616-3616). | detail... |
RET G810R | Advanced Solid Tumor | predicted - sensitive | APS03118 | Preclinical - Cell culture | Actionable | In a preclinical study, APS03118 inhibited the enzymatic activity of RET G810R in an in vitro assay and inhibited Ret phosphorylation and proliferation of cells expressing RET G810R in culture (J Clin Oncol 40, no. 16_suppl (June 1, 2022)). | detail... |